Pillar Pacific Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Pillar Pacific Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$4.57M	Buy	9,667 +449	+5%	+$219K	0.35%	91
2020 Q4	$4.45M	Sell	9,218 -24	-0.3%	-$13K	0.37%	87
2020 Q3	$5.17M	Buy	9,242 +3,867	+72%	+$2.34M	0.49%	76
2020 Q2	$3.35M	Buy	+5,375	New	+$3.05M	0.35%	90

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pillar Pacific Capital Management's REGN Position: Q1 2021 in Review

Pillar Pacific Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 4.9% in Q1 2021, buying an estimated $219K and bringing the position to 9,667 shares worth $4.57M. The position accounts for 0.35% of the portfolio, ranked #91.

Pillar Pacific Capital Management first reported a position in REGN in Q2 2020 and has held it in 4 quarters since. The position peaked at $5.17M in Q3 2020. 924 funds tracked by Wall St. Rank hold REGN as of Q1 2021.

Pillar Pacific Capital Management held 9,667 shares of Regeneron Pharmaceuticals worth $4.57M as of Q1 2021.
Pillar Pacific Capital Management bought 449 Regeneron Pharmaceuticals shares in Q1 2021, an estimated $219K.
Regeneron Pharmaceuticals made up 0.35% of Pillar Pacific Capital Management's portfolio in Q1 2021, its #91 holding.
Pillar Pacific Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 4 quarters since.
Pillar Pacific Capital Management's Regeneron Pharmaceuticals position peaked at $5.17M in Q3 2020.
924 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2021.

Based on Pillar Pacific Capital Management's 13F filing for Q1 2021, filed 4 May 2021.